Predictive Oncology Inc. (NASDAQ: POAI)
$1.13
+0.0150 ( +1.35% ) 51.8K
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
Market Data
Open
$1.13
Previous close
$1.11
Volume
51.8K
Market cap
$4.68M
Day range
$1.10 - $1.15
52 week range
$0.89 - $7.12
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Apr 08, 2024 |
10-k | Annual reports | 86 | Mar 28, 2024 |
8-k | 8K-related | 15 | Mar 28, 2024 |
8-k/a | 8K-related | 13 | Mar 22, 2024 |
8-k | 8K-related | 14 | Feb 08, 2024 |
8-k | 8K-related | 12 | Jan 04, 2024 |
def | Proxies and info statements | 3 | Dec 07, 2023 |
pre | Proxies and info statements | 3 | Dec 05, 2023 |
8-k | 8K-related | 14 | Nov 14, 2023 |
10-q | Quarterly Reports | 69 | Nov 13, 2023 |